BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) Stock News

NASDAQ:BBOT - KYG4444H1011 - Common Stock

9.3 USD

-0.29 (-2.97%)

Last: 8/27/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BBOT Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: TheRas, Inc. (d/b/a BBOT)

BBOT to Participate in Upcoming September Investor Healthcare Conferences

8 days ago - By: TheRas, Inc. (d/b/a BBOT)

BBOT to Participate in Upcoming September Investor Healthcare Conferences

17 days ago - By: TheRas, Inc. (d/b/a BBOT)

BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition

17 days ago - By: TheRas, Inc. (d/b/a BBOT)

BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition